DE69520882T2 - Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat - Google Patents

Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat

Info

Publication number
DE69520882T2
DE69520882T2 DE69520882T DE69520882T DE69520882T2 DE 69520882 T2 DE69520882 T2 DE 69520882T2 DE 69520882 T DE69520882 T DE 69520882T DE 69520882 T DE69520882 T DE 69520882T DE 69520882 T2 DE69520882 T2 DE 69520882T2
Authority
DE
Germany
Prior art keywords
clavunalate
potassium
preparation containing
medicinal preparation
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69520882T
Other languages
English (en)
Other versions
DE69520882D1 (de
Inventor
Ernest L G Rivett
Francis W Grimmett
Michael W Hartnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69520882D1 publication Critical patent/DE69520882D1/de
Application granted granted Critical
Publication of DE69520882T2 publication Critical patent/DE69520882T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69520882T 1994-08-17 1995-08-08 Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat Expired - Fee Related DE69520882T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416600A GB9416600D0 (en) 1994-08-17 1994-08-17 Pharmaceutical formulation
PCT/EP1995/003151 WO1996004908A1 (en) 1994-08-17 1995-08-08 Pharmaceutical formulation containing amoxycillin and potassium clavulanate

Publications (2)

Publication Number Publication Date
DE69520882D1 DE69520882D1 (de) 2001-06-13
DE69520882T2 true DE69520882T2 (de) 2002-01-10

Family

ID=10759965

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69520882T Expired - Fee Related DE69520882T2 (de) 1994-08-17 1995-08-08 Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat

Country Status (7)

Country Link
US (2) US5910322A (de)
EP (1) EP0776206B1 (de)
JP (1) JPH10504818A (de)
AT (1) ATE200981T1 (de)
DE (1) DE69520882T2 (de)
GB (1) GB9416600D0 (de)
WO (1) WO1996004908A1 (de)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9407386D0 (en) 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
ATE208618T1 (de) 1995-09-07 2001-11-15 Smithkline Beecham Corp Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AT407701B (de) * 1996-08-12 2001-05-25 Biochemie Gmbh Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
AT407214B (de) * 1996-03-13 2001-01-25 Biochemie Gmbh Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US7179486B1 (en) * 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
KR100502478B1 (ko) * 1997-06-13 2005-12-02 동아제약주식회사 클라불란산과베타락탐계항생물질을포함하는세균감염증치료제용약학적조성물
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
CN100382782C (zh) * 1999-04-13 2008-04-23 比彻姆药品(Pte)有限公司 一种释放改良型药用制剂
GB2365337A (en) * 1999-04-13 2002-02-20 Beecham Pharma Amoxycillin and potassium clavulanate high dosage regimen
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US7025989B2 (en) 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
AU3984101A (en) 2000-02-24 2001-09-03 Advanced Pharma Inc Antibiotic and antifungal compositions
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
AU3986901A (en) * 2000-02-24 2001-09-03 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6924253B2 (en) * 2000-04-07 2005-08-02 Bentley J. Palmer Scale removal
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US8012504B2 (en) 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7985420B2 (en) 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
AU2001279284A1 (en) * 2000-07-05 2002-01-14 Capricorn Pharma, Inc Rapid-melt semi-solid compositions, methods of making same and methods of using same
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
JP2004529902A (ja) * 2001-03-13 2004-09-30 ペンウェスト ファーマシューティカルズ カンパニー グルココルチコステロイドを含有する時間治療（ｃｈｒｏｎｏｔｈｅｒａｐｅｕｔｉｃ）投与形態
DE20321347U1 (de) * 2002-04-12 2006-10-26 Edscha Cabrio-Dachsysteme Gmbh Verdeck für ein Cabriolet-Fahrzeug
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
EP1648407A4 (de) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
EP1648415A4 (de) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1658034A4 (de) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc Antibiotisches produkt, seine verwendung und formulierung
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CN1882316A (zh) * 2003-09-19 2006-12-20 宾韦斯特医药公司 延迟释放剂型
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
CA2550983C (en) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
WO2005065685A1 (en) * 2004-01-06 2005-07-21 Panacea Biotec Ltd. Controlled release pharmaceutical composition comprising an acid-insoluble polymer and a bioadhesive polymer
WO2005099672A1 (en) * 2004-04-13 2005-10-27 Ranbaxy Laboratories Limited A modified release pharmaceutical formulation comprising amoxicillin and clavulanate
FR2872044B1 (fr) * 2004-06-28 2007-06-29 Flamel Technologies Sa Formulation pharmaceutique a base d'antibiotique sous forme microcapsulaire
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
DE06769529T1 (de) 2006-01-27 2009-04-16 Schlumberger Holdings Ltd. Verfahren zur hydraulischen spaltenbildung einer unterirdischen formation
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9120963B2 (en) * 2006-11-08 2015-09-01 Schlumberger Technology Corporation Delayed water-swelling materials and methods of use
WO2009063916A1 (ja) * 2007-11-16 2009-05-22 Asahi Kasei Chemicals Corporation 水系フィルムコーティング液、および、フィルムコーティング顆粒、ならびに、これを用いた錠剤
JP5101324B2 (ja) * 2008-02-07 2012-12-19 日立建機株式会社 建設機械のＮＯｘ低減装置の配設構造
US8839865B2 (en) * 2008-02-27 2014-09-23 Schlumberger Technology Corporation Slip-layer fluid placement
US9097077B2 (en) * 2009-10-30 2015-08-04 Schlumberger Technology Corporation Downhole chemical delivery system and method
US9234415B2 (en) 2010-08-25 2016-01-12 Schlumberger Technology Corporation Delivery of particulate material below ground
US8448706B2 (en) 2010-08-25 2013-05-28 Schlumberger Technology Corporation Delivery of particulate material below ground
US8714248B2 (en) 2010-08-25 2014-05-06 Schlumberger Technology Corporation Method of gravel packing
US8459353B2 (en) 2010-08-25 2013-06-11 Schlumberger Technology Corporation Delivery of particulate material below ground
MX2015017218A (es) 2013-06-13 2016-12-16 Griffith Laboratories Uso de almidones resistentes en composiciones de revestimiento.
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation
AU2017295866A1 (en) 2016-07-14 2019-01-17 Achaogen, Inc. Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
CA3205786A1 (en) * 2021-02-23 2022-09-01 Otsuka Pharmaceutical Co., Ltd. Centanafadine pharmaceutical formulations, and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US5679789A (en) * 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
GB9407386D0 (en) * 1994-04-14 1994-06-08 Smithkline Beecham Plc Pharmaceutical formulation
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
US5827537A (en) * 1995-05-04 1998-10-27 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
ATE243516T1 (de) * 1997-02-14 2003-07-15 Glaxosmithkline Lab Sas Amoxicillin und clavulanat enthaltende arzneizubereitungen

Also Published As

Publication number Publication date
WO1996004908A1 (en) 1996-02-22
JPH10504818A (ja) 1998-05-12
DE69520882D1 (de) 2001-06-13
GB9416600D0 (en) 1994-10-12
US5910322A (en) 1999-06-08
EP0776206A1 (de) 1997-06-04
EP0776206B1 (de) 2001-05-09
US6299903B1 (en) 2001-10-09
ATE200981T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
ATE200981T1 (de) Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat
MY115351A (en) Pharmaceutical formulations
DE69532415D1 (de) Schmelzextrudierte oral verabreichbare opioidformulierungen
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
AU4882597A (en) Pharmaceutical preparations for the controlled release of beta-lactam antibiotics
NO980081D0 (no) Farmasöytiske preparater
IL141762A0 (en) New oral formulations
MY100721A (en) Therapeutic agent.
IL131201A (en) Pharmaceutical formulations comprising amoxycillin and clavulanate
FI944035A (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
MY128809A (en) Pharmaceutical formulation of omeprazole
HUP9901437A3 (en) Pharmaceutical formulation, containing amoxycillin and clavulanate
HK1010836A1 (en) Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole
WO2000061116A3 (en) Pharmaceutical formulation comprising amoxycillin and clavulanate
CY1107909T1 (el) Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
AU2003246566A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU4929400A (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
AU3860797A (en) Pharmaceutical formulations for oral administration
ATA172297A (de) Pharmazeutische orale zusammensetzung enthaltend fk506
AU1880599A (en) Pharmaceutical composition for oral administration
JO1821B1 (en) New pharmaceutical product

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee